THE MCMANUS GROUP

Lobbying for SIGHT SCIENCES · Ophthalmic Medical Device company

Filing 1st Quarter - Termination

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $20,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Medicare/Medicaid

Issues related to modernizing payment policy for comprehensive minimally invasive glaucoma surgery procedures.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.